TRACI GRAY: Open Payments
NPI 1831759547 · JENA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 76 payments from 16 companies in 2025. Trend: 2023 $550 · 2024 $1,295 · 2025 $1,523
Food & beverage: $1,423Education: $100
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $381 |
| Astellas Pharma US Inc | 10 | $256 |
| ABBVIE INC. | 15 | $208 |
| Janssen Pharmaceuticals, Inc | 6 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| Indivior Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 4 | $66 |
| Braeburn Inc. | 3 | $60 |
| Lilly USA, LLC | 3 | $55 |
| PFIZER INC. | 3 | $54 |
Products named: Auvelity, Veozah, SPRAVATO, QULIPTA, CAPLYTA, VRAYLAR, SUBLOCADE, REXULTI.
Industry payments across LA — which companies pay providers there.
